Medicare AdvantageDocumentationMedium impact
MA08.012d, Off-label Coverage for Prescription Drugs and/or Biologics
Independence Blue Cross·Pharmacy
Effective date
Sep 22, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage has updated medical necessity criteria for off-label coverage of prescription drugs and biologics under policy MA08.012d. This change affects how providers must document and justify prescribing medications for uses not approved by the FDA.
Action Required
Before September 22, 2025: Providers must review and update documentation requirements for off-label prescription drug and biologic prescriptions for Medicare Advantage patients. Update EMR templates to ensure medical necessity criteria are properly documented according to new MA08.012d guidelines. Billing team should verify prior authorization requirements for off-label drug coverage to prevent claim denials.